North America Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivatives (CBD, THC), By Cultivation, By End Use (Medical, Recreational, Industrial), By Region, And Segment Forecasts, 2024

The North America legal cannabis market size is expected to reach USD 82.18 billion by 2030, registering a CAGR of 11.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as legalization of cannabis, growing awareness about the therapeutic benefits of cannabis-based products, and rising use of cannabis for medical & recreational purposes. Cannabis-derived products are widely used for treating patients suffering from chronic conditions, such as cancer, Parkinson's disease, Alzheimer's disease, and arthritis.

Moreover, the rising number of clinical trials signifies the positive effects of utilizing cannabis for treating various medical conditions. For instance, a clinical study published by Sage Journal in May 2023 reported that non-inhaled medical cannabis or cannabinoids result in a very small to small improvement in pain relief, sleep quality, and physical functioning in patients suffering from chronic pain. Thus, such positive results increase the demand for cannabis-based medicines in this region.

Incorporating artificial intelligence (AI) and robotics into cannabis cultivation enhances efficiency and standardizes yields by offering advanced crop management and prediction capabilities. This technology reduces costs and the need for manual labor by incorporating data analysis from various indicators, such as environmental conditions and soil quality, forecasting potential problems, optimizing growing practices, and managing resources effectively. For instance, in June 2024, PURPLEFARM,a Canadian company, partnered with Neatleaf, an AI company, to optimize and automate its cannabis cultivation processes using the Neatleaf Spyder system.

Some of the key players in the market are Canopy Growth Corporation, Charlotte's Web, Inc., Aurora Cannabis, Tilray Brands, The Cronos Group, Jazz Pharmaceuticals, Inc., Sundial Growers, and Medipharm Labs. These companies adopt key strategic initiatives to expand their business footprint and market position. For instance, in November 2022, Charlotte's Web Inc. entered a strategic alliance with Tilray, a Canada-based cannabis packaged goods company. This alliance allows Charlotte to manufacture and distribute its CBD hemp extract offerings in Canada.

North America Legal Cannabis Market Report Highlights:

By source, the marijuana segment dominated the market in 2023 and is anticipated to witness the fastest growth over the forecast period owing to the growing adoption of marijuana products along with the increasing legalization of medical marijuana
By derivatives, the CBD segment held the largest market share in 2023, owing to the rising use of CBD for various medical applications and awareness regarding its effectiveness in treating various medical conditions
By cultivation, the indoor segment held the largest market share in 2023 due to rising investments, technological advancements & innovations, favorable government initiatives, and regulatory framework
By end use, the recreational segment dominated the market in 2023 and is anticipated to grow at the fastest CAGR over the forecast period due to the growing adoption of cannabis vape pens among youths and increased use of cannabis for recreational purposes
In 2023, the U.S. accounted for the largest market share in the North America legal cannabis market, owing to favorable reimbursement policies for medical cannabis and the positive attitude of consumers towards cannabis utilization

Product Code: GVR-4-68039-828-0

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Source outlook
- 2.2.2. Derivatives outlook
- 2.2.3. Cultivation outlook
- 2.2.4. End Use outlook
- 2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. North America Legal Cannabis Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
3.3. North America Legal Cannabis: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTLE Analysis
3.4. Regulatory Framework

Chapter 4. North America Legal Cannabis Market Segment Analysis, By Source, 2018 - 2030 (USD Million)

4.1. Definition and Scope
4.2. Product Market Share Analysis, 2023 & 2030
4.3. Segment Dashboard
4.4. North America Legal Cannabis market, by Source, 2018 to 2030
4.5. Marijuana
- 4.5.1. Marijuana market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.2. Flowers
  - 4.5.2.1. Flowers market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.3. Oil and Tinctures
  - 4.5.3.1. Oil and Tinctures market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Hemp
- 4.6.1. Hemp market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6.2. Hemp CBD
  - 4.6.2.1. Hemp CBD market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6.3. Industrial Hemp
  - 4.6.3.1. Industrial Hemp market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. North America Legal Cannabis Market Segment Analysis, By Derivatives, 2018 - 2030 (USD Million)

5.1. Definition and Scope
5.2. Derivatives Market Share Analysis, 2023 & 2030
5.3. Segment Dashboard
5.4. North America Legal Cannabis market, by Derivatives, 2018 to 2030
5.5. CBD
- 5.5.1. CBD market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. THC
- 5.6.1. THC market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Other derivatives
- 5.7.1. Other derivatives market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. North America Legal Cannabis Market Segment Analysis, By Cultivation, 2018 - 2030 (USD Million)

6.1. Definition and Scope
6.2. Cultivation Market Share Analysis, 2023 & 2030
6.3. Segment Dashboard
6.4. North America Legal Cannabis market, by Cultivation, 2018 to 2030
6.5. Indoor Cultivation
- 6.5.1. Indoor Cultivation market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Greenhouse Cultivation
- 6.6.1. Greenhouse Cultivation market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Outdoor Cultivation
- 6.7.1. Outdoor Cultivation market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. North America Legal Cannabis Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

7.1. Definition and Scope
7.2. End Use Market Share Analysis, 2023 & 2030
7.3. Segment Dashboard
7.4. Global North America Legal Cannabis Market, by End Use, 2018 to 2030
7.5. Medical Use
- 7.5.1. Medical Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Cancer
  - 7.5.2.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Chronic Pain
  - 7.5.3.1. Chronic Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. Depression and Anxiety
  - 7.5.4.1. Depression and Anxiety Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Arthritis
  - 7.5.5.1. Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Diabetes
  - 7.5.6.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Glaucoma
  - 7.5.7.1. Glaucoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.8. Migraine
  - 7.5.8.1. Migraine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.9. Epilepsy
  - 7.5.9.1. Epilepsy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.10. Multiple Sclerosis
  - 7.5.10.1. Multiple Sclerosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.11. AIDS
  - 7.5.11.1. AIDS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.12. Amyotrophic Lateral Sclerosis
  - 7.5.12.1. Amyotrophic Lateral Sclerosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.13. Alzheimer's
  - 7.5.13.1. Alzheimer's Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.14. Post Traumatic Stress Disorder (PTSD)
  - 7.5.14.1. Post Traumatic Stress Disorder (PTSD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.15. Parkinson's
  - 7.5.15.1. Parkinson's Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.16. Tourette's
  - 7.5.16.1. Tourette's Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.17. Others
  - 7.5.17.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Recreational Use
- 7.6.1. Recreational Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Industrial Use
- 7.7.1. Industrial Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. North America Legal Cannabis Market Segment Analysis, By Region, By Product, By Material, By End Use, 2018- 2030 (USD Million)

8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Regional Market Snapshot
8.4. North America Legal Cannabis Market Share by Region, 2023 & 2030:
8.5. North America
- 8.5.1. North America Legal Cannabis market, 2018 - 2030 (USD Million)
- 8.5.2. U.S.
  - 8.5.2.1. U.S. Legal Cannabis market, 2018 - 2030 (USD Million)
- 8.5.3. Canada
  - 8.5.3.1. Canada Legal Cannabis market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company Categorization
9.3. Company Profiles
- 9.3.1. Canopy Growth Corporation
  - 9.3.1.1. Company overview
  - 9.3.1.2. Financial performance
  - 9.3.1.3. Product benchmarking
  - 9.3.1.4. Strategic initiatives
- 9.3.2. Charlotte's Web, Inc.
  - 9.3.2.1. Company overview
  - 9.3.2.2. Financial performance
  - 9.3.2.3. Product benchmarking
  - 9.3.2.4. Strategic initiatives
- 9.3.3. Aurora Cannabis Inc.
  - 9.3.3.1. Company overview
  - 9.3.3.2. Financial performance
  - 9.3.3.3. Product benchmarking
  - 9.3.3.4. Strategic initiatives
- 9.3.4. Tilray Brands
  - 9.3.4.1. Company overview
  - 9.3.4.2. Financial performance
  - 9.3.4.3. Product benchmarking
  - 9.3.4.4. Strategic initiatives
- 9.3.5. The Cronos Group
  - 9.3.5.1. Company overview
  - 9.3.5.2. Financial performance
  - 9.3.5.3. Product benchmarking
  - 9.3.5.4. Strategic initiatives
- 9.3.6. Jazz Pharmaceuticals, Inc.
  - 9.3.6.1. Company overview
  - 9.3.6.2. Financial performance
  - 9.3.6.3. Product benchmarking
  - 9.3.6.4. Strategic initiatives
- 9.3.7. Sundial Growers
  - 9.3.7.1. Company overview
  - 9.3.7.2. Financial performance
  - 9.3.7.3. Product benchmarking
  - 9.3.7.4. Strategic initiatives
- 9.3.8. Medipharm Labs
  - 9.3.8.1. Company overview
  - 9.3.8.2. Financial performance
  - 9.3.8.3. Product benchmarking
  - 9.3.8.4. Strategic initiatives
- 9.3.9. NuLeaf Naturals, LLC
  - 9.3.9.1. Company overview
  - 9.3.9.2. Financial performance
  - 9.3.9.3. Product benchmarking
  - 9.3.9.4. Strategic initiatives
- 9.3.10. Irwin Naturals
  - 9.3.10.1. Company overview
  - 9.3.10.2. Financial performance
  - 9.3.10.3. Product benchmarking
  - 9.3.10.4. Strategic initiatives

Product Code: GVR-4-68039-828-0

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 North America legal cannabis market, by source, 2018 - 2030 (USD Million)
Table 4 North America legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 5 North America legal cannabis market, by end use, 2018 - 2030 (USD Million)
Table 6 North America North America legal cannabis market, by cultivation, 2018 - 2030 (USD Million)
Table 7 North America North America legal cannabis market, by region, 2018 - 2030 (USD Million)
Table 8 U.S legal cannabis market, by source, 2018 - 2030 (USD Million)
Table 9 U.S legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 10 U.S legal cannabis market, by cultivation, 2018 - 2030 (USD Million)
Table 11 U.S legal cannabis market, by end use, 2018 - 2030 (USD Million)
Table 12 Canada legal cannabis market, by source, 2018 - 2030 (USD Million)
Table 13 Canada legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 14 Canada legal cannabis market, by cultivation, 2018 - 2030 (USD Million)
Table 15 Canada legal cannabis market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 North America legal cannabis market: outlook
Fig. 9 North America legal cannabis competitive insights
Fig. 10 Ancillary market outlook
Fig. 11 North America legal cannabis market driver impact
Fig. 12 North America legal cannabis market restraint impact
Fig. 13 Porter's Analysis
Fig. 14 PESTLE Analysis
Fig. 15 North America legal cannabis market: Source movement analysis
Fig. 16 North America legal cannabis market: Source outlook and key takeaways
Fig. 17 Marijuana market estimates and forecast, 2018 - 2030
Fig. 18 Flowers market estimates and forecast, 2018 - 2030
Fig. 19 Oil and Tinctures market estimates and forecast, 2018 - 2030
Fig. 20 Hemp market estimates and forecast, 2018 - 2030
Fig. 21 Hemp CBD market estimates and forecast, 2018 - 2030
Fig. 22 Industrial Hemp market estimates and forecast, 2018 - 2030
Fig. 23 North America legal cannabis market: Derivatives movement analysis
Fig. 24 North America legal cannabis market: Derivatives outlook and key takeaways
Fig. 25 CBD market estimates and forecasts, 2018 - 2030
Fig. 26 THC market estimates and forecasts, 2018 - 2030
Fig. 27 Other derivatives market estimates and forecasts, 2018 - 2030
Fig. 28 North America legal cannabis market: Cultivation movement analysis
Fig. 29 North America legal cannabis market: Cultivation outlook and key takeaways
Fig. 30 Indoor Cultivation market estimates and forecasts, 2018 - 2030
Fig. 31 Greenhouse Cultivation market estimates and forecasts, 2018 - 2030
Fig. 32 Outdoor Cultivation market estimates and forecasts, 2018 - 2030
Fig. 33 North America legal cannabis market: End Use movement analysis
Fig. 34 North America legal cannabis market: End Use outlook and key takeaways
Fig. 35 Medical Use market estimates and forecasts, 2018 - 2030
Fig. 36 Chronic Pain market estimates and forecasts, 2018 - 2030
Fig. 37 Depression and Anxiety market estimates and forecasts, 2018 - 2030
Fig. 38 Post-Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018 - 2030
Fig. 39 Arthritis market estimates and forecasts, 2018 - 2030
Fig. 40 Migraines market estimates and forecasts, 2018 - 2030
Fig. 41 Cancer market estimates and forecasts, 2018 - 2030
Fig. 42 Epilepsy market estimates and forecasts, 2018 - 2030
Fig. 43 Alzheimer's market estimates and forecasts, 2018 - 2030
Fig. 44 Multiple Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 45 Diabetes market estimates and forecasts, 2018 - 2030
Fig. 46 Tourette's market estimates and forecasts, 2018 - 2030
Fig. 47 Parkinson's market estimates and forecasts, 2018 - 2030
Fig. 48 AIDS market estimates and forecasts, 2018 - 2030
Fig. 49 Glaucoma market estimates and forecasts, 2018 - 2030
Fig. 50 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 51 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 52 Others market estimates and forecasts, 2018 - 2030
Fig. 53 Recreational Use market estimates and forecasts, 2018 - 2030
Fig. 54 Industrial Use market estimates and forecasts, 2018 - 2030
Fig. 55 North America legal cannabis market: Regional movement analysis
Fig. 56 North America legal cannabis market: Regional outlook and key takeaways
Fig. 57 North America North America legal cannabis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 U.S. legal cannabis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 Canada legal cannabis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Key company categorization
Fig. 64 Heat map analysis, 2022 - 2023

North America Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivatives (CBD, THC), By Cultivation, By End Use (Medical, Recreational, Industrial), By Region, And Segment Forecasts, 2024 - 2030

Description

Table of Contents

List of Tables

North America Legal Cannabis Market Growth & Trends:

North America Legal Cannabis Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. North America Legal Cannabis Market Variables, Trends & Scope

Chapter 4. North America Legal Cannabis Market Segment Analysis, By Source, 2018 - 2030 (USD Million)

Chapter 5. North America Legal Cannabis Market Segment Analysis, By Derivatives, 2018 - 2030 (USD Million)

Chapter 6. North America Legal Cannabis Market Segment Analysis, By Cultivation, 2018 - 2030 (USD Million)

Chapter 7. North America Legal Cannabis Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

Chapter 8. North America Legal Cannabis Market Segment Analysis, By Region, By Product, By Material, By End Use, 2018- 2030 (USD Million)

Chapter 9. Competitive Landscape

List of Tables

List of Figures